Maxcyte (MXCT) Non Operating Income (2020 - 2026)

Maxcyte (MXCT) has 7 years of Non Operating Income data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Non Operating Income fell 29.45% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 29.27% YoY) and the FY2025 annual result came in at $7.3 million, down 28.35% from the prior year.
• Non Operating Income retreated to $1.4 million in Q1 2026 per MXCT's latest filing, from $1.6 million in the prior quarter.
• Across five years, Non Operating Income topped out at $2.8 million in Q4 2023 and bottomed at $91800.0 in Q1 2022.
• The 5-year median for Non Operating Income is $2.0 million (2025), against an average of $1.9 million.
• The widest annual swing landed in 2022, when Non Operating Income jumped 10506.52%; it then tumbled 30.57% in 2025.
• Tracing MXCT's Non Operating Income over 5 years: stood at $1.9 million in 2022, then soared by 45.18% to $2.8 million in 2023, then slipped by 18.24% to $2.3 million in 2024, then retreated by 29.25% to $1.6 million in 2025, then dropped by 11.96% to $1.4 million in 2026.
• Per Business Quant, the three latest MXCT Non Operating Income figures stand at $1.4 million (Q1 2026), $1.6 million (Q4 2025), and $1.7 million (Q3 2025).

Peer Comparison